(Q38412036)

English

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

scientific article published on May 2015

In more languages
default for all languages
No label defined

No description defined

Statements

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection (English)
Lindsay Mollison
Jean-Pierre Bronowicki
Grisell Ortiz-Lasanta
Navdeep Boparai
E Scott Swenson
UNITY-1 Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit